Skip to main content
Top
Published in: European Radiology 2/2008

01-02-2008 | Urogenital

MR classification of renal masses with pathologic correlation

Authors: Ivan Pedrosa, Mary T. Chou, Long Ngo, Ronaldo H. Baroni, Elizabeth M. Genega, Laura Galaburda, William C. DeWolf, Neil M. Rofsky

Published in: European Radiology | Issue 2/2008

Login to get access

Abstract

To perform a feature analysis of malignant renal tumors evaluated with magnetic resonance (MR) imaging and to investigate the correlation between MR imaging features and histopathological findings. MR examinations in 79 malignant renal masses were retrospectively evaluated, and a feature analysis was performed. Each renal mass was assigned to one of eight categories from a proposed MRI classification system. The sensitivity and specificity of the MRI classification system to predict the histologic subtype and nuclear grade was calculated. Subvoxel fat on chemical shift imaging correlated to clear cell type (p < 0.05); sensitivity = 42%, specificity = 100%. Large size, intratumoral necrosis, retroperitoneal vascular collaterals, and renal vein thrombosis predicted high-grade clear cell type (p < 0.05). Small size, peripheral location, low intratumoral SI on T2-weighted images, and low-level enhancement were associated with low-grade papillary carcinomas (p < 0.05). The sensitivity and specificity of the MRI classification system for diagnosing low grade clear cell, high-grade clear cell, all clear cell, all papillary, and transitional carcinomas were 50% and 94%, 93% and 75%, 92% and 83%, 80% and 94%, and 100% and 99%, respectively. The MRI feature analysis and proposed classification system help predict the histological type and nuclear grade of renal masses.
Literature
1.
go back to reference Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203–205PubMedCrossRef Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203–205PubMedCrossRef
2.
go back to reference Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745PubMedCrossRef Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745PubMedCrossRef
3.
go back to reference Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS (2005) Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173:1853–1862PubMedCrossRef Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS (2005) Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173:1853–1862PubMedCrossRef
4.
go back to reference Stadler WM (2005) Targeted agents for the treatment of advanced renal cell carcinoma. Cancer 104:2323–2333PubMedCrossRef Stadler WM (2005) Targeted agents for the treatment of advanced renal cell carcinoma. Cancer 104:2323–2333PubMedCrossRef
5.
go back to reference Kaelin WG Jr (2004) The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 10:6290S–6295SPubMedCrossRef Kaelin WG Jr (2004) The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 10:6290S–6295SPubMedCrossRef
6.
go back to reference Hecht EM, Israel GM, Krinsky GA et al (2004) Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 232:373–378PubMedCrossRef Hecht EM, Israel GM, Krinsky GA et al (2004) Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 232:373–378PubMedCrossRef
7.
go back to reference Rofsky NM, Bosniak MA (1997) MR imaging in the evaluation of small (< or =3.0 cm) renal masses. Magn Reson Imaging Clin N Am 5:67–81PubMed Rofsky NM, Bosniak MA (1997) MR imaging in the evaluation of small (< or =3.0 cm) renal masses. Magn Reson Imaging Clin N Am 5:67–81PubMed
8.
go back to reference Rominger MB, Kenney PJ, Morgan DE, Bernreuter WK, Listinsky JJ (1992) Gadolinium-enhanced MR imaging of renal masses. Radiographics 12:1097–1116; discussion 1117–1098PubMed Rominger MB, Kenney PJ, Morgan DE, Bernreuter WK, Listinsky JJ (1992) Gadolinium-enhanced MR imaging of renal masses. Radiographics 12:1097–1116; discussion 1117–1098PubMed
9.
go back to reference Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll PR (1991) Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 178:803–809PubMed Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll PR (1991) Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 178:803–809PubMed
10.
go back to reference Semelka RC, Shoenut JP, Magro CM, Kroeker MA, MacMahon R, Greenberg HM (1993) Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging. J Magn Reson Imaging 3:597–602PubMedCrossRef Semelka RC, Shoenut JP, Magro CM, Kroeker MA, MacMahon R, Greenberg HM (1993) Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging. J Magn Reson Imaging 3:597–602PubMedCrossRef
11.
go back to reference Ho VB, Allen SF, Hood MN, Choyke PL (2002) Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 224:695–700PubMedCrossRef Ho VB, Allen SF, Hood MN, Choyke PL (2002) Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 224:695–700PubMedCrossRef
12.
go back to reference Bosniak MA (1986) The current radiological approach to renal cysts. Radiology 158:1–10PubMed Bosniak MA (1986) The current radiological approach to renal cysts. Radiology 158:1–10PubMed
13.
go back to reference Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN (1988) CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR Am J Roentgenol 151:497–501PubMed Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN (1988) CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR Am J Roentgenol 151:497–501PubMed
14.
go back to reference Eilenberg SS, Lee JK, Brown J, Mirowitz SA, Tartar VM (1990) Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Radiology 176:333–338PubMed Eilenberg SS, Lee JK, Brown J, Mirowitz SA, Tartar VM (1990) Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Radiology 176:333–338PubMed
15.
go back to reference Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231:365–371PubMedCrossRef Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231:365–371PubMedCrossRef
16.
go back to reference Semelka RC, Shoenut JP, Kroeker MA, MacMahon RG, Greenberg HM (1992) Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques [see comments]. Radiology 182:425–430PubMed Semelka RC, Shoenut JP, Kroeker MA, MacMahon RG, Greenberg HM (1992) Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques [see comments]. Radiology 182:425–430PubMed
17.
go back to reference Yoshimitsu K, Honda H, Kuroiwa T et al (1999) MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient-echo imaging. J Magn Reson Imaging 9:579–585PubMedCrossRef Yoshimitsu K, Honda H, Kuroiwa T et al (1999) MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient-echo imaging. J Magn Reson Imaging 9:579–585PubMedCrossRef
18.
go back to reference Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D (2007) MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol 17:193–200PubMedCrossRef Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D (2007) MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol 17:193–200PubMedCrossRef
19.
go back to reference Yoshimitsu K, Irie H, Tajima T et al (2004) MR imaging of renal cell carcinoma: its role in determining cell type. Radiat Med 22:371–376PubMed Yoshimitsu K, Irie H, Tajima T et al (2004) MR imaging of renal cell carcinoma: its role in determining cell type. Radiat Med 22:371–376PubMed
20.
go back to reference Earls J, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 202:268–273PubMed Earls J, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 202:268–273PubMed
21.
go back to reference Israel GM, Hindman N, Hecht E, Krinsky G (2005) The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 184:1868–1872PubMed Israel GM, Hindman N, Hecht E, Krinsky G (2005) The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 184:1868–1872PubMed
22.
go back to reference Zhang J, Pedrosa I, Rofsky NM (2003) MR techniques for renal imaging. Radiol Clin North Am 41:877–907PubMedCrossRef Zhang J, Pedrosa I, Rofsky NM (2003) MR techniques for renal imaging. Radiol Clin North Am 41:877–907PubMedCrossRef
23.
go back to reference Agresti A, Coull B (1998) Approximate is better than “exact” for interval estimation of binomial proportions. American Statistician 119–126 Agresti A, Coull B (1998) Approximate is better than “exact” for interval estimation of binomial proportions. American Statistician 119–126
24.
go back to reference Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175:425–431PubMedCrossRef Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175:425–431PubMedCrossRef
25.
go back to reference Kouba E, Smith A, McRackan D, Wallen EM, Pruthi RS (2007) Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177:466–470PubMedCrossRef Kouba E, Smith A, McRackan D, Wallen EM, Pruthi RS (2007) Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177:466–470PubMedCrossRef
26.
go back to reference Guinan P, Frank W, Saffrin R, Rubenstein M (1994) Staging and survival of patients with renal cell carcinoma. Semin Surg Oncol 10:47–50PubMedCrossRef Guinan P, Frank W, Saffrin R, Rubenstein M (1994) Staging and survival of patients with renal cell carcinoma. Semin Surg Oncol 10:47–50PubMedCrossRef
27.
go back to reference Kuczyk M, Wegener G, Merseburger AS et al (2005) Impact of tumor size on the long-term survival of patients with early stage renal cell cancer. World J Urol 23:50–54PubMedCrossRef Kuczyk M, Wegener G, Merseburger AS et al (2005) Impact of tumor size on the long-term survival of patients with early stage renal cell cancer. World J Urol 23:50–54PubMedCrossRef
28.
go back to reference Leibovich BC, Pantuck AJ, Bui MH et al (2003) Current staging of renal cell carcinoma. Urol Clin North Am 30:481–497, viiiPubMedCrossRef Leibovich BC, Pantuck AJ, Bui MH et al (2003) Current staging of renal cell carcinoma. Urol Clin North Am 30:481–497, viiiPubMedCrossRef
29.
go back to reference Han KR, Janzen NK, McWhorter VC et al (2004) Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol 22:410–414PubMed Han KR, Janzen NK, McWhorter VC et al (2004) Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol 22:410–414PubMed
30.
go back to reference Mejean A, Hopirtean V, Bazin JP et al (2003) Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 170:764–767PubMedCrossRef Mejean A, Hopirtean V, Bazin JP et al (2003) Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 170:764–767PubMedCrossRef
31.
go back to reference Herts BR, Coll DM, Novick AC et al (2002) Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 178:367–372PubMed Herts BR, Coll DM, Novick AC et al (2002) Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 178:367–372PubMed
32.
go back to reference Turner KJ, Moore JW, Jones A et al (2002) Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62:2957–2961PubMed Turner KJ, Moore JW, Jones A et al (2002) Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62:2957–2961PubMed
33.
go back to reference Djordjevic G, Mozetic V, Mozetic DV et al (2007) Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma. Pathol Res Pract 203:99–106PubMedCrossRef Djordjevic G, Mozetic V, Mozetic DV et al (2007) Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma. Pathol Res Pract 203:99–106PubMedCrossRef
34.
go back to reference Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624PubMedCrossRef Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624PubMedCrossRef
35.
go back to reference Semenza GL (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14:1983–1991PubMed Semenza GL (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14:1983–1991PubMed
36.
go back to reference Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG (1997) Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 205:103–107PubMed Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG (1997) Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 205:103–107PubMed
37.
go back to reference Storkel S, Eble JN, Adlakha K et al (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:987–989PubMedCrossRef Storkel S, Eble JN, Adlakha K et al (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:987–989PubMedCrossRef
38.
go back to reference Kim JK, Kim SH, Jang YJ et al (2006) Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239:174–180PubMedCrossRef Kim JK, Kim SH, Jang YJ et al (2006) Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239:174–180PubMedCrossRef
39.
go back to reference Milner J, McNeil B, Alioto J et al (2006) Fat poor renal angiomyolipoma: patient, computerized tomography and histological findings. J Urol 176:905–909PubMedCrossRef Milner J, McNeil B, Alioto J et al (2006) Fat poor renal angiomyolipoma: patient, computerized tomography and histological findings. J Urol 176:905–909PubMedCrossRef
40.
go back to reference Korobkin M, Lombardi TJ, Aisen AM et al (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197:411–418PubMed Korobkin M, Lombardi TJ, Aisen AM et al (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197:411–418PubMed
41.
go back to reference Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S (1995) Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol 165:91–95PubMed Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S (1995) Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol 165:91–95PubMed
Metadata
Title
MR classification of renal masses with pathologic correlation
Authors
Ivan Pedrosa
Mary T. Chou
Long Ngo
Ronaldo H. Baroni
Elizabeth M. Genega
Laura Galaburda
William C. DeWolf
Neil M. Rofsky
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
European Radiology / Issue 2/2008
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-007-0757-0

Other articles of this Issue 2/2008

European Radiology 2/2008 Go to the issue